SlideShare a Scribd company logo
1 of 67
The role of somatic hypermutation and
AGY serine codons in (auto)immunity
Thiago Detanico
Wysocki Lab
The Germinal Center Reaction
Bone Marrow
Thymus
LN/Spleen
B cells
CD4T cells
T-B border
Germinal center,
affinity maturation and
somatic hypermutation
Plasma cells
Talk Outline
• Somatic hypermutation plays a predominant
role in generating anti-nucleosome antibodies.
• IgV genes are prone to acquire CDR-Arg
mutations and “autoreactivity”.
• AGY Ser codons are plastic and can easily
mutate to other key antigen-contact residues.
Systemic Lupus Erythematosus
• Is a systemic autoimmune disease.
• Is characterized by the presence of high-
avidity, IgG anti-nuclear antibodies, especially
nucleosome (breach in B cell tolerance).
The Origin of Autoimmune B cells
Development in BM
B cells “born” with autoreactive BCR participate in T-cell
dependent autoantibody responses.
Autoreactive B cell
traverses all tolerance
checkpoints
“Germline founder hypothesis”
V/D/J recombination
The Origin of Autoimmune B cells
“Mutation founder hypothesis”
Nonautoreactive
B cell stimulated by
immunogen
Somatic
hypermutation { Autoreactive B
cell
Somatic hypermutation creates the autoreactive B cell in a
germinal center from a previously normal B cell
(Escapes late tolerance checkpoint ?)
XMutation creates
autoreactivity
X
X
X
Predictions of mutation founder hypothesis
B cells (hybridomas) belonging to a common lineage should share at least
one somatic mutation producing an amino acid change conferring autoreactivity
Reverting ALL somatic mutations to germline sequence should eliminate
autoreactivity
Unmutated precursor
Additional mutations
may enhance affinity
for self-Ag
X
X
X
Autoreactive lineage (clone)
X
X
X
3; 2r
3; 1r
1r
J7.13
J2.8
2
17; 15r
7
5
4
7
41 1
1
6
6
6
6*
4
2*3
3
J5.8
1
J2.7
J10.7
J10.13
J3.8
J7.18
K5.14
J1.1
J3.4
7
J9.7
J3.1
K6.23
J1.4
J4.2
4
7; 4r
J5.5
J6.1
6; 5r
8; 5r
5
J3.9
J3.10
11r
11; 5r
6; 3r
34; 20r
16; 12r
6; 4r
J3.7
K6.18
3
+7 individuals
Six lineages, each with unanimously-shared somatic
mutations.
Dendrograms of lineages
9;7r
11; 8r
12,9r
N3.18
6
N12.6
+ 1 individual
Guo et al, J. Exp. Med. 2010
Supporting evidence for the
“Mutation Founder Hypothesis”
• In a system where every somatic mutation
could be identified (TdT-/-), we have
shown that the majority of anti-chromatin
antibodies were generated in the
periphery.
Only two out of thirty-three auto-
Abs were derived from a B cell
that was born autoreactive
Guo et al, J. Exp. Med. 2010
Mutated mAbs
Revertant mAbs “R”
Supporting evidence for the
“Mutation Founder Hypothesis”
• AID deficiency (no somatic hypermutation)
severely delays the development of anti-
nuclear antibodies in the B6.Nba2 lupus-prone
mouse.
Only 2 of 8 B6.Nba2 AID-/- mice
develop high-titers of the
prototypical anti-nucleosome Abs
Anti-Nucleosome
Detanico et al, J. Autoimm. 2015
Summary I
• In a system where every somatic mutation could be
identified (Tdt -/-), we have shown that reversion of
somatic mutations to a germline sequence, eliminated
detectable autoreactivity in a majority of clones.
• In an autoimmune mouse model, where no somatic
hypermutation was observed (AID deficiency), we
found that anti-nuclear responses were delayed and
severely diminished.
• Together these support the view that most IgG+ anti-
nuclear clones arise from nonautoreactive precursors
via somatic hypermutation.
Talk Outline
• Somatic hypermutation plays a predominant
role in generating anti-nucleosome antibodies.
• IgV genes are prone to acquire CDR-Arg
mutations and “autoreactivity”.
• AGY Ser codons are plastic and can easily
mutate to other key antigen-contact residues.
Background
Is the creation of an ANA clone by SHM
a rare or frequent event?
• Arginine residues contribute substantially
to antibody affinity for nuclear antigens.
• Arginine residues often arise by somatic
hypermutation of AGC and AGT (AGY)
serine codons.
• AGY Ser codons are prone to mutate to
Arg codons.
AGY Ser codons can mutate to Arg
residues by three different nucleotide
replacements.
AGY Ser codons
(X)GY=Arg, if X=C
AG(X)=Arg, if X=A or G
Arg codons
SHM
Do IgV genes have high
frequencies of AGY Ser codons?
Rationale: High frequencies of AGY codons may lead to a high frequency of
somatically generated Arg residues and autoreactivity.
High frequencies of AGY Ser codons
among IgV CDR sequences.
CDR1&2
FR1,2&3
CDR1&2
FR1,2&3
CDR1&2
FR1,2&3
CDR1&2
FR1,2&3
CDR1&2
FR1,2&3
CDR1&2
FR1,2&3
VH Vk VlVH Vk Vl
Mouse germline IgV genes
AGY Observed/Expected
Human germline IgV genes
AGY Observed/Expected
Ratio
..............................................................................................
_____ _______________ __________
BA
Expected Freq.= 0.016 or 1/61
(random codon usage)
Expected Freq. from codon
use tables
0
2
4
6
8
Do IgV genes have high
frequencies of Ser codons?
Rationale: If the high frequencies of AGY Ser codons use in CDRs were
merely due to a selection pressure favoring Ser residues among germline-
encoded CDR sequences, we would expect equally high frequencies of four
other serine codons (TCN).
H . sa p ie n s g e rm line Ig V -C D R se q ue nce s
0
2
4
6
8
V H V k V l
A GY
TC N
Ratio(Observed/Expected)
High frequencies of AGY, but not TCN
Ser codons among germline-encoded
human IgV-CDR sequences.
High frequencies of AGY, but not TCN
Ser codons among germline-encoded
mouse IgV-CDR sequences.
M . m u s c u lu s g e rm line Ig V -C D R s e q ue nc e s
0
2
4
6
8
V H V k V l
TC N
A GY
Ratio(Observed/Expected)
H. sapiens IgV genes
0
2
4
6
8 *** p=0.024
VH Vk Vl
***
Observed/CDR1&2
M. musculus IgV genes
0
2
4
6
8
***
***
p=0.157
VH Vk Vl
Observed/CDR1&2
Ser-AGY Ser-TCN
High frequencies of AGY over TCN Ser
codons among germline-encoded IgV-
CDR sequences.
High frequencies of AGY over TCN Ser
codons among germline-encoded IgV-
CDR sequences.
-4
-2
0
2
4
6
8
H. sapiens
Vl
n=39
VH
n=54
Vk
n=46
n=44 n=36 n=22
(AGYSer)-(TCNSer)/CDR1&2
-4
-2
0
2
4
6
8
Vl
n=3
VH
n=108
Vk
n=95
n=70 n=56 n=3
M. musculus
(AGYSer)-(TCNSer)/CDR1&2
How early in evolution did the
CDR AGY Ser codon bias appear?
Approach: Analyze IgV-CDR sequences from cartilaginous fishes.
The AGY Ser bias was established early
in evolution in IgVH-CDR.
Is the AGY Ser codon bias
restricted to IgV genes?
Approach: Compare mouse TCRV genes with IgV genes.
Mouse TCRV genes lack the AGY over
TCN Ser codon CDR bias.
TCRV  TCRV 
0
2
4
6
8
A G Y
T C N
Ratio(Observ
0
2
4
6
8
AGY
TCN
p=0.08 ***
TCRV TCRV
Number/CDR1&2
M. musculus TCRV CDR1&2
Is CDR AGY abundance driven by
selection pressure to focus
somatic mutation on CDRs?
Rationale: AGY triplets are a preferential AID target motif.
Approach: If AGY triplets were selected only on the basis of mutation then
other possible reading-frames should also be enriched.
AGY triplets are enriched in the Ser
reading-frame among CDR sequences.
NNAGYNN
CDR start: Ser-AGY
CDR start: nonSer-AGY
NNAGYNN
CDR end: Ser-AGY
CDR end: nonSer-AGY
Approach: If AGY triplets were selected only on the basis of mutation then
other possible reading-frames should be enriched too.
AGC triplets are enriched in the Ser
reading-frame among CDR sequences.
H. sapiens IgV genes
0
2
4
6
8
*** ***
p=0.002
VH Vk Vl
Number/CDR1&2
M. musculus IgV genes
0
2
4
6
8
*** ***
VH Vk Vl
p=1
Number/CDR1&2
Ser-AGC nonSer-AGC
AGT triplets are also enriched in the
Ser reading-frame among CDRs.
H. sapiens IgV genes
0
2
4
6
8
***
***
VH Vk Vl
***
Number/CDR1&2
M. musculus IgV genes
0
2
4
6
8
p=0.47
***
VH Vk Vl
p=0.02
Number/CDR1&2
Ser-AGT nonSer-AGT
Is the highly mutable AGCT
sequence also selectively
enriched in the Ser reading
frame?
Rationale: AGCT sequence is often target by AID during somatic
hypermutation.
Approach: If AGCT sequences were selected only on the basis of mutation
then other possible reading-frames should be enriched too.
AGCT palindromic sequence is
enriched in the Ser reading-frame
among CDRs.
Approach: If AGCT sequences were selected only on the basis of mutation
then other possible reading-frames should be enriched too.
NNNAGCTNN
CDR start: Ser-AGCT
CDR start: nonSer-AGCT
CDR start: not counted
NNNAGCTNN
CDR end: Ser-AGCT
CDR end: nonSer-AGCT
AGCT palindromic sequence is
enriched in the Ser reading-frame
among CDRs.
0
1
2
3
4
*** p=0.0258
VH Vk Vl
p=0.002
Observed/CDR1&2
0
1
2
3
4
***
p=0.346
VH Vk Vl
***
Observed/CDR1&2
Ser-AGCT nonSer-AGCT
H. sapiens IgV genes M. musculus IgV genes
Summary II
Evidence for evolutionary selection pressure to have AGY Ser
codons among IgV-CDR sequences
• CDR, but not FR sequences from IgV genes have
high frequencies of AGY Ser codons.
• AGY triplets in IgV genes were enriched in the Ser
codon reading-frame
• This phenomenon is restricted to IgV genes (not
seen in TCRV genes), and occurred early in
evolution.
Talk Outline
• Somatic hypermutation plays a predominant
role in generating anti-nucleosome antibodies.
• IgV genes are prone to acquire CDR-Arg
mutations and “autoreactivity”.
• AGY Ser codons are plastic and can easily
mutate to other key antigen-contact residues.
Rationale
Several groups have shown that
polyreactive/autoreactive Abs play an important
role in immune responses to enveloped
viruses.
Background
• AGY Ser codons are enriched among IgV-CDR
sequences and are a preferential target for AID.
• AGY readily mutate to Arg codons.
• CDR-Arg codons are often a signature of anti-
nuclear antibodies.
• HIV broadly neutralizing antibodies are often
autoreactive.
Are mutations that create Arg codons
associated with HIV broadly
neutralizing antibodies?
Approach: Analyze published HIV broadly neutralizing antibody
sequences for the presence of somatically generated arginine codons.
Arg residues often arise by somatic
mutation of AGY Ser codon in HIV
broadly neutralizing Abs.
*Database: http://bnaber.org/
n=49 n=49
47
32
Any Arg Ser Arg
HIV bNAbs
Somatically generated Arg codon
Do somatically generated Arg
residues frequently occur in antibody
responses against other viruses?
Approach: Analyze other available antibody sequences for the presence of
somatically generated Arg residues.
Arg residues arise often by somatic
hypermutation of CDR-AGY Ser codons.
Influenza#1
Influenza#2
Rhinovirus
AvianInfluenza
WestNile
Dengue
Hepatitis
A,B&C
0.0
0.2
0.4
0.6
0.8
1.0
5
10
15
20
25
Total IgV replacements (CDRs & FRs)
Total Arg by SHM (CDRs & FRs)
AGY-Ser to Arg (CDRs only)
#ofaminoacidreplacements/
germline-encodedIgVgene
Do AGY Ser codons preferentially
mutate only to Arg codons in
anti-viral Abs?
Approach: Analyze available antibody sequences for the presence of
replacement mutations in AGY Ser codons.
Germline-encoded AGY Ser codons often
mutate into Asn, Arg, Gly and Thr during
viral immune responses.
Viruses Asn Gly Thr Arg Others #mut CDR-AGY
Influenza1 22% 11% 21% 10% 36% 146
Influenza2 30% 11% 25% 16% 18% 126
West Nile 20% 0% 60% 20% 0% 5
Dengue 14% 0% 43% 29% 14% 7
Rhinovirus 7% 0% 15% 26% 52% 27
Avian Influenza 50% 0% 17% 33% 0% 13
Hep. A, B & C 22% 18% 18% 20% 22% 72
Average 23.6% 5.7% 28.4% 22% 20%
Analysis of many crystal structures
of antigen-antibody interactions have
shown that 7 amino acids are often
observed as contact residues.
Tyr
Arg
Asn
Asp
Gly
Ser
Thr
Raghunathan G. at all, J. Mol. Recognition. 2012; 25:103-113
AGY Ser codons can easily mutate into 4 out
of the 7 residues by one nucleotide change,
or stay unchanged (5 out of 7).
AGY Ser
A(X)Y=Asn, if X=A
A(X)Y=Thr, if X=C
(X)GY=Gly, if X=G
(X)GY=Arg, if X=C
AG(X)=Arg, if X=G or A
AG(X)=Ser, if X=C or T
Preferential target for the 2nd and 3rd
nucleotide bases in germline-encoded
AGY Ser triplets.
Viruses (X)GY A(X)Y AG(X) 2 changes 3 changes #mut CDR-AGY
Influenza1 12% 53% 11% 20% 4% 146
Influenza2 11% 52% 15% 20% 2% 126
West Nile 0% 80% 20% 0% 0% 5
Dengue 15% 57% 14% 14% 0% 7
Rhinovirus 0% 22% 19% 52% 7% 27
Avian Influenza 0% 67% 33% 0% 0% 13
Hep. A, B & C 12% 35% 18% 35% 0% 72
Average 7.1% 52.3% 18.6% 20.1% 1.9%
Summary III
The autoreactive potential of AGY Ser codons may be a small cost to
pay for such plastic codons.
• Somatic hypermutation of AGY Ser codons often
creates Arg codons, but also creates Asn, Gly and
Thr residues.
• AGY Ser codons easily mutate into Arg, Asn, Gly
and Thr codons by one nucleotide change.
• Crystal structures of antibody-antigen interactions
have shown that Arg, Asn, Asp, Gly, Ser, Thr and Tyr
antibody residues are often contact residues.
Conclusions
• Anti-nuclear specificity arises frequently by
somatic hypermutation of AGY Ser codons.
• Autoreactivity may be the price of having such
a plastic codon in the CDRs.
• Sometimes weak autoreactivity may be
beneficial to immune responses.
Model: Mutational plasticity of AGY Ser
codons supports affinity maturation.
Tyr
Arg
Asn
Asp
Gly
AGY Ser
Thr
Acknowledgments
Wyscoki Lab:
• Larry Wysocki
• Katja Aviszus
Kappler/Marrack Lab:
• Mathew Phillips
Funding:
R01AI093822
R21AI113122
Key contact amino acids are often observed at
germline-encoded IgV CDR sequences.
Germline-encoded CDR1&2 amino acid usage (IgV genes average)
Met
Thr
Asn
Lys
Ser(AGY)
Ser(Total)
Arg
Val
Ala
Asp
Glu
Gly
Phe
Leu
Tyr
Cys
Trp
Pro
His
Gln
Ile
0
2
4
6
8
Ratio(Observed/Expected)
Human
Mouse
AGY-Ser is the predominant
contact residue target during SHM
A n t ib o d y - A n t ig e n C o n t a c t R e s id u e s ( H + L )
Met-->Any
Thr-->Any
Asn-->Any
Lys-->Any
Ser-->Any
Arg-->Any
Val-->Any
Ala-->Any
Asp-->Any
Glu-->Any
Gly-->Any
Phe-->Any
Leu-->Any
Tyr-->Any
Cys-->Any
Trp-->Any
Pro-->Any
His-->Any
Gln-->Any
Ile-->Any
0
1 0
2 0
3 0
4 0
5 0
M . m u s c u lu s
H . s a p i e n s
Germlinecodonx1
TotalSHMcontac
AGY-Ser and Asn easily mutate to polar residues by
one nucleotide change.
Function Mutability Index
Asn
Ser(AGY)
Ala
Asp
Pro
Cys
Trp
Tyr
Gly
Arg(CGN)
Lys
Thr
Arg(AGR)
Gln
Glu
Ile
Val
Leu(CTN)
Met
Phe
Ser(TCN)
Leu(TTR)
0
2
4
6
8
Ratio
[Polar/(nonPolar+stop)]
Why autoimmunity is the
exception?
Somatic hypermutation of the BCR cannot
account solely to the stochastic nature of
autoimmunity
*We think that autoreactive B cells are often
created by somatic hypermutation in the Germinal
Center.
Similar kinetics between Tumor
and Lupus-like models
p53-/- (NZBxNZW)F1
Age (weeks)
Jacks et al, Current Biology 1994 Ishida et al, J Exp Med 1994
The delayed kinetics in p53-/- is
due to the requirement of several
mutations in other genes prior to
tumor clonal expansion.
non-tumor
cells from
p53-/-
1st mutation
2nd mutation
several mutations
tumor
growth/survival
Hypothesis:
• To overcome the several tiers of tolerance, an
autoimmune B cell must first acquire several
mutations in immunoregulatory genes.
The Stochastic Event Model
non-autoimmune B cells
autoimmune B cell
tolerance
checkpoints
autoimmune B cell is
eliminated from the B cell
repertory.
autoimmune B cell
tolerance
checkpoints
somatic mutations
in regulatory pathways
survival/growth of
autoimmune B
cells
non-autoimmune B cells
The Stochastic Event Model
So how can we test it?
• Requires to isolate an anti-nuclear B cell.
• Requires to expand a single anti-nuclear B cell.
• Sequence the whole genome for mutations.
• Caveat: So far we were unable to isolate an anti-
nuclear B cell.
So we decided to develop a BCR heavy
and light-chain knock in mouse, where
we can track and control the fate of an
anti-nuclear B cell.
The kappa switch (KS) knock in mouse
Non autoreactive light-chain Autoreactive light-chain
B cells are born with a non autoreactive light-chain, however upon Cre-
expression, the autoreactive light-chain substitutes the non
autoreactive light-chain, creating an anti-nuclear B cell when paired
with a particular heavy-chain.
NEO VkJkCk-IRES-mCherry VkJkCk-IRES-GFPL
Surprisingly KS+ B cells
express both reporter genes at
low levels.
mCherry GFP
B220+ gate
wt
KS+
wt
KS+
Excision of the NEO gene by FLP
increases expression of reporter genes.mCherry
B220
GFP
wt KS+Neo+ KS+FLP+
Acknowledgments
Wyscoki Lab:
• Larry Wysocki
• Katja Aviszus
Kappler/Marrack Lab:
• Mathew Phillips
Funding:
R01AI093822
R21AI113122

More Related Content

What's hot

Coreceptor usage
Coreceptor usageCoreceptor usage
Coreceptor usage
makarandptl
 
Research Poster
Research PosterResearch Poster
Research Poster
Cody Wong
 
Ociit conference 2010 final
Ociit conference 2010 finalOciit conference 2010 final
Ociit conference 2010 final
bek1826
 
SKGF_Presentation_New Patent Issues Surrounding Therapeutic Antibodies_2007
SKGF_Presentation_New Patent Issues Surrounding Therapeutic Antibodies_2007SKGF_Presentation_New Patent Issues Surrounding Therapeutic Antibodies_2007
SKGF_Presentation_New Patent Issues Surrounding Therapeutic Antibodies_2007
SterneKessler
 
The Vertebrate Genome Annotation Database
The Vertebrate Genome Annotation DatabaseThe Vertebrate Genome Annotation Database
The Vertebrate Genome Annotation Database
EBI
 
J. Virol.-2016-Patil-JVI.03090-15
J. Virol.-2016-Patil-JVI.03090-15J. Virol.-2016-Patil-JVI.03090-15
J. Virol.-2016-Patil-JVI.03090-15
SHILPA PATIL
 
Research Abstract
Research AbstractResearch Abstract
Research Abstract
John O'Hara
 

What's hot (20)

6 26-2012
6 26-20126 26-2012
6 26-2012
 
Karn lessons-hiv-latency-2014-10-06
Karn lessons-hiv-latency-2014-10-06Karn lessons-hiv-latency-2014-10-06
Karn lessons-hiv-latency-2014-10-06
 
Coreceptor usage
Coreceptor usageCoreceptor usage
Coreceptor usage
 
ZhouPoster
ZhouPosterZhouPoster
ZhouPoster
 
Research Poster
Research PosterResearch Poster
Research Poster
 
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild ...
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild ...Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild ...
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild ...
 
Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine ...
Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine ...Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine ...
Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine ...
 
Chromatin looping as a target for altering gene expression
Chromatin looping as a target for altering gene expressionChromatin looping as a target for altering gene expression
Chromatin looping as a target for altering gene expression
 
Immunisatie1
Immunisatie1Immunisatie1
Immunisatie1
 
Computational approaches to cell cycle analysis: Current research topics (tho...
Computational approaches to cell cycle analysis: Current research topics (tho...Computational approaches to cell cycle analysis: Current research topics (tho...
Computational approaches to cell cycle analysis: Current research topics (tho...
 
Ociit conference 2010 final
Ociit conference 2010 finalOciit conference 2010 final
Ociit conference 2010 final
 
nihms498914
nihms498914nihms498914
nihms498914
 
SKGF_Presentation_New Patent Issues Surrounding Therapeutic Antibodies_2007
SKGF_Presentation_New Patent Issues Surrounding Therapeutic Antibodies_2007SKGF_Presentation_New Patent Issues Surrounding Therapeutic Antibodies_2007
SKGF_Presentation_New Patent Issues Surrounding Therapeutic Antibodies_2007
 
The Vertebrate Genome Annotation Database
The Vertebrate Genome Annotation DatabaseThe Vertebrate Genome Annotation Database
The Vertebrate Genome Annotation Database
 
Transplant immunology final ppt
Transplant immunology final pptTransplant immunology final ppt
Transplant immunology final ppt
 
Zeine & Owens, J. Neuroimmunology 1993
Zeine & Owens, J. Neuroimmunology 1993Zeine & Owens, J. Neuroimmunology 1993
Zeine & Owens, J. Neuroimmunology 1993
 
J. Virol.-2016-Patil-JVI.03090-15
J. Virol.-2016-Patil-JVI.03090-15J. Virol.-2016-Patil-JVI.03090-15
J. Virol.-2016-Patil-JVI.03090-15
 
Research Abstract
Research AbstractResearch Abstract
Research Abstract
 
GKA deel 2 college 11
GKA deel 2 college 11GKA deel 2 college 11
GKA deel 2 college 11
 
Gal-9 Sigma Xi ppt
Gal-9 Sigma Xi pptGal-9 Sigma Xi ppt
Gal-9 Sigma Xi ppt
 

Viewers also liked

เทคนิคการทําภาพขอบจุดกระจาย
เทคนิคการทําภาพขอบจุดกระจายเทคนิคการทําภาพขอบจุดกระจาย
เทคนิคการทําภาพขอบจุดกระจาย
Aon Chainarong
 
Una mañana de piscina
Una mañana de piscinaUna mañana de piscina
Una mañana de piscina
julilajara
 
Aria the scalet ammo
Aria the scalet ammoAria the scalet ammo
Aria the scalet ammo
alluchiha
 
Sediment Remediation - Technical Update
Sediment Remediation - Technical UpdateSediment Remediation - Technical Update
Sediment Remediation - Technical Update
webern
 
ThiagoDetanico Resume 13May2016
ThiagoDetanico Resume 13May2016ThiagoDetanico Resume 13May2016
ThiagoDetanico Resume 13May2016
Thiago Detanico
 
Intuit
IntuitIntuit
Intuit
ssalha
 

Viewers also liked (15)

เทคนิคการทําภาพขอบจุดกระจาย
เทคนิคการทําภาพขอบจุดกระจายเทคนิคการทําภาพขอบจุดกระจาย
เทคนิคการทําภาพขอบจุดกระจาย
 
Una mañana de piscina
Una mañana de piscinaUna mañana de piscina
Una mañana de piscina
 
PROYECTO EMPROSILO S.A.S
PROYECTO EMPROSILO S.A.SPROYECTO EMPROSILO S.A.S
PROYECTO EMPROSILO S.A.S
 
Aria the scalet ammo
Aria the scalet ammoAria the scalet ammo
Aria the scalet ammo
 
video
videovideo
video
 
Gottby: En myndighets perspektiv på Fiberbankar
Gottby: En myndighets perspektiv på FiberbankarGottby: En myndighets perspektiv på Fiberbankar
Gottby: En myndighets perspektiv på Fiberbankar
 
Gintama
GintamaGintama
Gintama
 
Sediment Remediation - Technical Update
Sediment Remediation - Technical UpdateSediment Remediation - Technical Update
Sediment Remediation - Technical Update
 
ThiagoDetanico Resume 13May2016
ThiagoDetanico Resume 13May2016ThiagoDetanico Resume 13May2016
ThiagoDetanico Resume 13May2016
 
Software administrativo
Software administrativoSoftware administrativo
Software administrativo
 
Paradigma Positivista
Paradigma PositivistaParadigma Positivista
Paradigma Positivista
 
Las emociones
Las emocionesLas emociones
Las emociones
 
Module 1 Ang Mga Katangian ng Pagpapakatao
Module 1  Ang Mga Katangian ng PagpapakataoModule 1  Ang Mga Katangian ng Pagpapakatao
Module 1 Ang Mga Katangian ng Pagpapakatao
 
Maximizing profits through facilities
Maximizing profits through facilities Maximizing profits through facilities
Maximizing profits through facilities
 
Intuit
IntuitIntuit
Intuit
 

Similar to RIP 24Feb2016v4

Sequencing the Human TCRβ Repertoire on the Ion S5TM
Sequencing the Human TCRβ Repertoire on the Ion S5TMSequencing the Human TCRβ Repertoire on the Ion S5TM
Sequencing the Human TCRβ Repertoire on the Ion S5TM
Thermo Fisher Scientific
 
Lessons learned from high throughput CRISPR targeting in human cell lines
Lessons learned from high throughput CRISPR targeting in human cell linesLessons learned from high throughput CRISPR targeting in human cell lines
Lessons learned from high throughput CRISPR targeting in human cell lines
Chris Thorne
 
Biotechnology review power point
Biotechnology review power pointBiotechnology review power point
Biotechnology review power point
Megan Elizabeth
 

Similar to RIP 24Feb2016v4 (20)

Structureandfunctionofimmunesystem 170119044924
Structureandfunctionofimmunesystem 170119044924Structureandfunctionofimmunesystem 170119044924
Structureandfunctionofimmunesystem 170119044924
 
Sequencing the Human TCRβ Repertoire on the Ion S5TM
Sequencing the Human TCRβ Repertoire on the Ion S5TMSequencing the Human TCRβ Repertoire on the Ion S5TM
Sequencing the Human TCRβ Repertoire on the Ion S5TM
 
Antibody diversity presentation
Antibody diversity presentationAntibody diversity presentation
Antibody diversity presentation
 
155 dna microarray
155 dna microarray155 dna microarray
155 dna microarray
 
155 dna microarray
155 dna microarray155 dna microarray
155 dna microarray
 
Dna microarray mehran
Dna microarray  mehranDna microarray  mehran
Dna microarray mehran
 
Antibody therapy and engineering
Antibody therapy and engineeringAntibody therapy and engineering
Antibody therapy and engineering
 
r-DNA Technology
r-DNA Technologyr-DNA Technology
r-DNA Technology
 
Mdadar 3
Mdadar   3Mdadar   3
Mdadar 3
 
cloning and sub-cloning
cloning and sub-cloningcloning and sub-cloning
cloning and sub-cloning
 
Microarray
MicroarrayMicroarray
Microarray
 
HLA typing.ppt
HLA typing.pptHLA typing.ppt
HLA typing.ppt
 
Widespread human T cell receptor beta variable gene polymorphism: implication...
Widespread human T cell receptor beta variable gene polymorphism: implication...Widespread human T cell receptor beta variable gene polymorphism: implication...
Widespread human T cell receptor beta variable gene polymorphism: implication...
 
Introduction to novel antibody sequencing technique
Introduction to novel antibody sequencing techniqueIntroduction to novel antibody sequencing technique
Introduction to novel antibody sequencing technique
 
Lessons learned from high throughput CRISPR targeting in human cell lines
Lessons learned from high throughput CRISPR targeting in human cell linesLessons learned from high throughput CRISPR targeting in human cell lines
Lessons learned from high throughput CRISPR targeting in human cell lines
 
Gene cloning
Gene cloningGene cloning
Gene cloning
 
Ab diversity
Ab diversityAb diversity
Ab diversity
 
Genes
GenesGenes
Genes
 
Biotechnology review power point
Biotechnology review power pointBiotechnology review power point
Biotechnology review power point
 
Discovering my research interest by eric garson sheffield university 2017
Discovering my research interest by eric garson   sheffield university 2017Discovering my research interest by eric garson   sheffield university 2017
Discovering my research interest by eric garson sheffield university 2017
 

RIP 24Feb2016v4

  • 1. The role of somatic hypermutation and AGY serine codons in (auto)immunity Thiago Detanico Wysocki Lab
  • 2. The Germinal Center Reaction Bone Marrow Thymus LN/Spleen B cells CD4T cells T-B border Germinal center, affinity maturation and somatic hypermutation Plasma cells
  • 3. Talk Outline • Somatic hypermutation plays a predominant role in generating anti-nucleosome antibodies. • IgV genes are prone to acquire CDR-Arg mutations and “autoreactivity”. • AGY Ser codons are plastic and can easily mutate to other key antigen-contact residues.
  • 4. Systemic Lupus Erythematosus • Is a systemic autoimmune disease. • Is characterized by the presence of high- avidity, IgG anti-nuclear antibodies, especially nucleosome (breach in B cell tolerance).
  • 5. The Origin of Autoimmune B cells Development in BM B cells “born” with autoreactive BCR participate in T-cell dependent autoantibody responses. Autoreactive B cell traverses all tolerance checkpoints “Germline founder hypothesis” V/D/J recombination
  • 6. The Origin of Autoimmune B cells “Mutation founder hypothesis” Nonautoreactive B cell stimulated by immunogen Somatic hypermutation { Autoreactive B cell Somatic hypermutation creates the autoreactive B cell in a germinal center from a previously normal B cell (Escapes late tolerance checkpoint ?)
  • 7. XMutation creates autoreactivity X X X Predictions of mutation founder hypothesis B cells (hybridomas) belonging to a common lineage should share at least one somatic mutation producing an amino acid change conferring autoreactivity Reverting ALL somatic mutations to germline sequence should eliminate autoreactivity Unmutated precursor Additional mutations may enhance affinity for self-Ag X X X Autoreactive lineage (clone) X X X
  • 8. 3; 2r 3; 1r 1r J7.13 J2.8 2 17; 15r 7 5 4 7 41 1 1 6 6 6 6* 4 2*3 3 J5.8 1 J2.7 J10.7 J10.13 J3.8 J7.18 K5.14 J1.1 J3.4 7 J9.7 J3.1 K6.23 J1.4 J4.2 4 7; 4r J5.5 J6.1 6; 5r 8; 5r 5 J3.9 J3.10 11r 11; 5r 6; 3r 34; 20r 16; 12r 6; 4r J3.7 K6.18 3 +7 individuals Six lineages, each with unanimously-shared somatic mutations. Dendrograms of lineages 9;7r 11; 8r 12,9r N3.18 6 N12.6 + 1 individual Guo et al, J. Exp. Med. 2010
  • 9. Supporting evidence for the “Mutation Founder Hypothesis” • In a system where every somatic mutation could be identified (TdT-/-), we have shown that the majority of anti-chromatin antibodies were generated in the periphery.
  • 10. Only two out of thirty-three auto- Abs were derived from a B cell that was born autoreactive Guo et al, J. Exp. Med. 2010 Mutated mAbs Revertant mAbs “R”
  • 11. Supporting evidence for the “Mutation Founder Hypothesis” • AID deficiency (no somatic hypermutation) severely delays the development of anti- nuclear antibodies in the B6.Nba2 lupus-prone mouse.
  • 12. Only 2 of 8 B6.Nba2 AID-/- mice develop high-titers of the prototypical anti-nucleosome Abs Anti-Nucleosome Detanico et al, J. Autoimm. 2015
  • 13. Summary I • In a system where every somatic mutation could be identified (Tdt -/-), we have shown that reversion of somatic mutations to a germline sequence, eliminated detectable autoreactivity in a majority of clones. • In an autoimmune mouse model, where no somatic hypermutation was observed (AID deficiency), we found that anti-nuclear responses were delayed and severely diminished. • Together these support the view that most IgG+ anti- nuclear clones arise from nonautoreactive precursors via somatic hypermutation.
  • 14. Talk Outline • Somatic hypermutation plays a predominant role in generating anti-nucleosome antibodies. • IgV genes are prone to acquire CDR-Arg mutations and “autoreactivity”. • AGY Ser codons are plastic and can easily mutate to other key antigen-contact residues.
  • 15. Background Is the creation of an ANA clone by SHM a rare or frequent event? • Arginine residues contribute substantially to antibody affinity for nuclear antigens. • Arginine residues often arise by somatic hypermutation of AGC and AGT (AGY) serine codons. • AGY Ser codons are prone to mutate to Arg codons.
  • 16. AGY Ser codons can mutate to Arg residues by three different nucleotide replacements. AGY Ser codons (X)GY=Arg, if X=C AG(X)=Arg, if X=A or G Arg codons SHM
  • 17. Do IgV genes have high frequencies of AGY Ser codons? Rationale: High frequencies of AGY codons may lead to a high frequency of somatically generated Arg residues and autoreactivity.
  • 18. High frequencies of AGY Ser codons among IgV CDR sequences. CDR1&2 FR1,2&3 CDR1&2 FR1,2&3 CDR1&2 FR1,2&3 CDR1&2 FR1,2&3 CDR1&2 FR1,2&3 CDR1&2 FR1,2&3 VH Vk VlVH Vk Vl Mouse germline IgV genes AGY Observed/Expected Human germline IgV genes AGY Observed/Expected Ratio .............................................................................................. _____ _______________ __________ BA Expected Freq.= 0.016 or 1/61 (random codon usage) Expected Freq. from codon use tables 0 2 4 6 8
  • 19. Do IgV genes have high frequencies of Ser codons? Rationale: If the high frequencies of AGY Ser codons use in CDRs were merely due to a selection pressure favoring Ser residues among germline- encoded CDR sequences, we would expect equally high frequencies of four other serine codons (TCN).
  • 20. H . sa p ie n s g e rm line Ig V -C D R se q ue nce s 0 2 4 6 8 V H V k V l A GY TC N Ratio(Observed/Expected) High frequencies of AGY, but not TCN Ser codons among germline-encoded human IgV-CDR sequences.
  • 21. High frequencies of AGY, but not TCN Ser codons among germline-encoded mouse IgV-CDR sequences. M . m u s c u lu s g e rm line Ig V -C D R s e q ue nc e s 0 2 4 6 8 V H V k V l TC N A GY Ratio(Observed/Expected)
  • 22. H. sapiens IgV genes 0 2 4 6 8 *** p=0.024 VH Vk Vl *** Observed/CDR1&2 M. musculus IgV genes 0 2 4 6 8 *** *** p=0.157 VH Vk Vl Observed/CDR1&2 Ser-AGY Ser-TCN High frequencies of AGY over TCN Ser codons among germline-encoded IgV- CDR sequences.
  • 23. High frequencies of AGY over TCN Ser codons among germline-encoded IgV- CDR sequences. -4 -2 0 2 4 6 8 H. sapiens Vl n=39 VH n=54 Vk n=46 n=44 n=36 n=22 (AGYSer)-(TCNSer)/CDR1&2 -4 -2 0 2 4 6 8 Vl n=3 VH n=108 Vk n=95 n=70 n=56 n=3 M. musculus (AGYSer)-(TCNSer)/CDR1&2
  • 24. How early in evolution did the CDR AGY Ser codon bias appear? Approach: Analyze IgV-CDR sequences from cartilaginous fishes.
  • 25. The AGY Ser bias was established early in evolution in IgVH-CDR.
  • 26. Is the AGY Ser codon bias restricted to IgV genes? Approach: Compare mouse TCRV genes with IgV genes.
  • 27. Mouse TCRV genes lack the AGY over TCN Ser codon CDR bias. TCRV  TCRV  0 2 4 6 8 A G Y T C N Ratio(Observ 0 2 4 6 8 AGY TCN p=0.08 *** TCRV TCRV Number/CDR1&2 M. musculus TCRV CDR1&2
  • 28. Is CDR AGY abundance driven by selection pressure to focus somatic mutation on CDRs? Rationale: AGY triplets are a preferential AID target motif. Approach: If AGY triplets were selected only on the basis of mutation then other possible reading-frames should also be enriched.
  • 29. AGY triplets are enriched in the Ser reading-frame among CDR sequences. NNAGYNN CDR start: Ser-AGY CDR start: nonSer-AGY NNAGYNN CDR end: Ser-AGY CDR end: nonSer-AGY Approach: If AGY triplets were selected only on the basis of mutation then other possible reading-frames should be enriched too.
  • 30. AGC triplets are enriched in the Ser reading-frame among CDR sequences. H. sapiens IgV genes 0 2 4 6 8 *** *** p=0.002 VH Vk Vl Number/CDR1&2 M. musculus IgV genes 0 2 4 6 8 *** *** VH Vk Vl p=1 Number/CDR1&2 Ser-AGC nonSer-AGC
  • 31. AGT triplets are also enriched in the Ser reading-frame among CDRs. H. sapiens IgV genes 0 2 4 6 8 *** *** VH Vk Vl *** Number/CDR1&2 M. musculus IgV genes 0 2 4 6 8 p=0.47 *** VH Vk Vl p=0.02 Number/CDR1&2 Ser-AGT nonSer-AGT
  • 32. Is the highly mutable AGCT sequence also selectively enriched in the Ser reading frame? Rationale: AGCT sequence is often target by AID during somatic hypermutation. Approach: If AGCT sequences were selected only on the basis of mutation then other possible reading-frames should be enriched too.
  • 33. AGCT palindromic sequence is enriched in the Ser reading-frame among CDRs. Approach: If AGCT sequences were selected only on the basis of mutation then other possible reading-frames should be enriched too. NNNAGCTNN CDR start: Ser-AGCT CDR start: nonSer-AGCT CDR start: not counted NNNAGCTNN CDR end: Ser-AGCT CDR end: nonSer-AGCT
  • 34. AGCT palindromic sequence is enriched in the Ser reading-frame among CDRs. 0 1 2 3 4 *** p=0.0258 VH Vk Vl p=0.002 Observed/CDR1&2 0 1 2 3 4 *** p=0.346 VH Vk Vl *** Observed/CDR1&2 Ser-AGCT nonSer-AGCT H. sapiens IgV genes M. musculus IgV genes
  • 35. Summary II Evidence for evolutionary selection pressure to have AGY Ser codons among IgV-CDR sequences • CDR, but not FR sequences from IgV genes have high frequencies of AGY Ser codons. • AGY triplets in IgV genes were enriched in the Ser codon reading-frame • This phenomenon is restricted to IgV genes (not seen in TCRV genes), and occurred early in evolution.
  • 36. Talk Outline • Somatic hypermutation plays a predominant role in generating anti-nucleosome antibodies. • IgV genes are prone to acquire CDR-Arg mutations and “autoreactivity”. • AGY Ser codons are plastic and can easily mutate to other key antigen-contact residues.
  • 37. Rationale Several groups have shown that polyreactive/autoreactive Abs play an important role in immune responses to enveloped viruses.
  • 38. Background • AGY Ser codons are enriched among IgV-CDR sequences and are a preferential target for AID. • AGY readily mutate to Arg codons. • CDR-Arg codons are often a signature of anti- nuclear antibodies. • HIV broadly neutralizing antibodies are often autoreactive.
  • 39. Are mutations that create Arg codons associated with HIV broadly neutralizing antibodies? Approach: Analyze published HIV broadly neutralizing antibody sequences for the presence of somatically generated arginine codons.
  • 40. Arg residues often arise by somatic mutation of AGY Ser codon in HIV broadly neutralizing Abs. *Database: http://bnaber.org/ n=49 n=49 47 32 Any Arg Ser Arg HIV bNAbs Somatically generated Arg codon
  • 41. Do somatically generated Arg residues frequently occur in antibody responses against other viruses? Approach: Analyze other available antibody sequences for the presence of somatically generated Arg residues.
  • 42. Arg residues arise often by somatic hypermutation of CDR-AGY Ser codons. Influenza#1 Influenza#2 Rhinovirus AvianInfluenza WestNile Dengue Hepatitis A,B&C 0.0 0.2 0.4 0.6 0.8 1.0 5 10 15 20 25 Total IgV replacements (CDRs & FRs) Total Arg by SHM (CDRs & FRs) AGY-Ser to Arg (CDRs only) #ofaminoacidreplacements/ germline-encodedIgVgene
  • 43. Do AGY Ser codons preferentially mutate only to Arg codons in anti-viral Abs? Approach: Analyze available antibody sequences for the presence of replacement mutations in AGY Ser codons.
  • 44. Germline-encoded AGY Ser codons often mutate into Asn, Arg, Gly and Thr during viral immune responses. Viruses Asn Gly Thr Arg Others #mut CDR-AGY Influenza1 22% 11% 21% 10% 36% 146 Influenza2 30% 11% 25% 16% 18% 126 West Nile 20% 0% 60% 20% 0% 5 Dengue 14% 0% 43% 29% 14% 7 Rhinovirus 7% 0% 15% 26% 52% 27 Avian Influenza 50% 0% 17% 33% 0% 13 Hep. A, B & C 22% 18% 18% 20% 22% 72 Average 23.6% 5.7% 28.4% 22% 20%
  • 45. Analysis of many crystal structures of antigen-antibody interactions have shown that 7 amino acids are often observed as contact residues. Tyr Arg Asn Asp Gly Ser Thr Raghunathan G. at all, J. Mol. Recognition. 2012; 25:103-113
  • 46. AGY Ser codons can easily mutate into 4 out of the 7 residues by one nucleotide change, or stay unchanged (5 out of 7). AGY Ser A(X)Y=Asn, if X=A A(X)Y=Thr, if X=C (X)GY=Gly, if X=G (X)GY=Arg, if X=C AG(X)=Arg, if X=G or A AG(X)=Ser, if X=C or T
  • 47. Preferential target for the 2nd and 3rd nucleotide bases in germline-encoded AGY Ser triplets. Viruses (X)GY A(X)Y AG(X) 2 changes 3 changes #mut CDR-AGY Influenza1 12% 53% 11% 20% 4% 146 Influenza2 11% 52% 15% 20% 2% 126 West Nile 0% 80% 20% 0% 0% 5 Dengue 15% 57% 14% 14% 0% 7 Rhinovirus 0% 22% 19% 52% 7% 27 Avian Influenza 0% 67% 33% 0% 0% 13 Hep. A, B & C 12% 35% 18% 35% 0% 72 Average 7.1% 52.3% 18.6% 20.1% 1.9%
  • 48. Summary III The autoreactive potential of AGY Ser codons may be a small cost to pay for such plastic codons. • Somatic hypermutation of AGY Ser codons often creates Arg codons, but also creates Asn, Gly and Thr residues. • AGY Ser codons easily mutate into Arg, Asn, Gly and Thr codons by one nucleotide change. • Crystal structures of antibody-antigen interactions have shown that Arg, Asn, Asp, Gly, Ser, Thr and Tyr antibody residues are often contact residues.
  • 49. Conclusions • Anti-nuclear specificity arises frequently by somatic hypermutation of AGY Ser codons. • Autoreactivity may be the price of having such a plastic codon in the CDRs. • Sometimes weak autoreactivity may be beneficial to immune responses.
  • 50. Model: Mutational plasticity of AGY Ser codons supports affinity maturation. Tyr Arg Asn Asp Gly AGY Ser Thr
  • 51. Acknowledgments Wyscoki Lab: • Larry Wysocki • Katja Aviszus Kappler/Marrack Lab: • Mathew Phillips Funding: R01AI093822 R21AI113122
  • 52. Key contact amino acids are often observed at germline-encoded IgV CDR sequences. Germline-encoded CDR1&2 amino acid usage (IgV genes average) Met Thr Asn Lys Ser(AGY) Ser(Total) Arg Val Ala Asp Glu Gly Phe Leu Tyr Cys Trp Pro His Gln Ile 0 2 4 6 8 Ratio(Observed/Expected) Human Mouse
  • 53. AGY-Ser is the predominant contact residue target during SHM A n t ib o d y - A n t ig e n C o n t a c t R e s id u e s ( H + L ) Met-->Any Thr-->Any Asn-->Any Lys-->Any Ser-->Any Arg-->Any Val-->Any Ala-->Any Asp-->Any Glu-->Any Gly-->Any Phe-->Any Leu-->Any Tyr-->Any Cys-->Any Trp-->Any Pro-->Any His-->Any Gln-->Any Ile-->Any 0 1 0 2 0 3 0 4 0 5 0 M . m u s c u lu s H . s a p i e n s Germlinecodonx1 TotalSHMcontac
  • 54. AGY-Ser and Asn easily mutate to polar residues by one nucleotide change. Function Mutability Index Asn Ser(AGY) Ala Asp Pro Cys Trp Tyr Gly Arg(CGN) Lys Thr Arg(AGR) Gln Glu Ile Val Leu(CTN) Met Phe Ser(TCN) Leu(TTR) 0 2 4 6 8 Ratio [Polar/(nonPolar+stop)]
  • 55. Why autoimmunity is the exception?
  • 56. Somatic hypermutation of the BCR cannot account solely to the stochastic nature of autoimmunity *We think that autoreactive B cells are often created by somatic hypermutation in the Germinal Center.
  • 57. Similar kinetics between Tumor and Lupus-like models p53-/- (NZBxNZW)F1 Age (weeks) Jacks et al, Current Biology 1994 Ishida et al, J Exp Med 1994
  • 58. The delayed kinetics in p53-/- is due to the requirement of several mutations in other genes prior to tumor clonal expansion. non-tumor cells from p53-/- 1st mutation 2nd mutation several mutations tumor growth/survival
  • 59. Hypothesis: • To overcome the several tiers of tolerance, an autoimmune B cell must first acquire several mutations in immunoregulatory genes.
  • 60. The Stochastic Event Model non-autoimmune B cells autoimmune B cell tolerance checkpoints autoimmune B cell is eliminated from the B cell repertory.
  • 61. autoimmune B cell tolerance checkpoints somatic mutations in regulatory pathways survival/growth of autoimmune B cells non-autoimmune B cells The Stochastic Event Model
  • 62. So how can we test it? • Requires to isolate an anti-nuclear B cell. • Requires to expand a single anti-nuclear B cell. • Sequence the whole genome for mutations. • Caveat: So far we were unable to isolate an anti- nuclear B cell.
  • 63. So we decided to develop a BCR heavy and light-chain knock in mouse, where we can track and control the fate of an anti-nuclear B cell.
  • 64. The kappa switch (KS) knock in mouse Non autoreactive light-chain Autoreactive light-chain B cells are born with a non autoreactive light-chain, however upon Cre- expression, the autoreactive light-chain substitutes the non autoreactive light-chain, creating an anti-nuclear B cell when paired with a particular heavy-chain. NEO VkJkCk-IRES-mCherry VkJkCk-IRES-GFPL
  • 65. Surprisingly KS+ B cells express both reporter genes at low levels. mCherry GFP B220+ gate wt KS+ wt KS+
  • 66. Excision of the NEO gene by FLP increases expression of reporter genes.mCherry B220 GFP wt KS+Neo+ KS+FLP+
  • 67. Acknowledgments Wyscoki Lab: • Larry Wysocki • Katja Aviszus Kappler/Marrack Lab: • Mathew Phillips Funding: R01AI093822 R21AI113122